Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2005, p. 2449-2451, Vol. 43, No. 5
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.5.2449-2451.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Vaccine Preventable Bacterial Diseases Division, National Microbiology Laboratory, Population and Public Health Branch, Health Canada, Winnipeg, Manitoba, Canada,1 Swedish Institute for Infectious Disease Control, Solna, Sweden,2 Division of Bacteriology, National Institute for Biological Standards and Controls, Blanche Lane, Potters Bar, United Kingdom3
Received 26 November 2004/ Returned for modification 4 January 2005/ Accepted 6 January 2005
Sixty-one Bordetella pertussis isolates were tested blindly in two laboratories to determine their serotype nature by monoclonal antibodies using two independent methods: the standard bacterial microagglutination assay and an indirect whole-cell enzyme-linked immunosorbent assay. Both methods gave concordant results in 60 of the 61 isolates.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»